HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 402.89 Thousand | 315.78 Thousand | 115.45 Thousand | 57.39 Thousand | 209.21 Thousand | 77.16 Thousand |
| Cost of Revenue | 906.99 Thousand | 629.93 Thousand | 418.27 Thousand | 421.61 Thousand | 510.07 Thousand | 134.07 Thousand |
| Gross Profit | -504.09 Thousand | -314.15 Thousand | -302.82 Thousand | -364.22 Thousand | -300.86 Thousand | -56.9 Thousand |
| Operating Expenses | 6.78 Million | 4.27 Million | 4.94 Million | 4.64 Million | 4.34 Million | 2.81 Million |
| Selling, General and Administrative Expenses | 4.25 Million | 3.18 Million | 2.92 Million | 2.93 Million | 3.01 Million | 2.13 Million |
| Research and Development Expenses | 2.63 Million | 1.09 Million | 2.01 Million | 1.71 Million | 1.32 Million | 678.31 Thousand |
| Other Expenses | - | - | - | 88.92 Thousand | 69.27 Thousand | 208.32 Thousand |
| Cost and Expenses | 7.01 Million | 4.9 Million | 5.36 Million | 5.07 Million | 4.85 Million | 2.95 Million |
| Operating Income | -6.42 Million | -4.58 Million | -5.24 Million | -5.01 Million | -4.64 Million | -2.87 Million |
| Interest Expense | 89.63 Thousand | 2.5 Million | 2.23 Million | 14.99 Thousand | 10.72 Thousand | 891.57 Thousand |
| Income Tax Expense | 3.00 | 5.00 | 125.43 Thousand | -3.00 | 2.00 | 891.57 Thousand |
| Earnings before Tax | -6.78 Million | -7.04 Million | -7.6 Million | -4.87 Million | -4.5 Million | -3.76 Million |
| Net Income | -6.78 Million | -7.04 Million | -7.6 Million | -4.87 Million | -4.5 Million | -3.76 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 |
| Earnings Per Share Diluted | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 |
| Weighted Average Shares Outstanding | 266.25 Million | 218.86 Million | 178.49 Million | 128.56 Million | 90.47 Million | 87.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 266.25 Million | 218.86 Million | 178.49 Million | 128.56 Million | 90.47 Million | 87.52 Million |
| Gross Margin | -1.25 | -0.99 | -2.62 | -6.35 | -1.44 | -0.74 |
| EBIT Margin | -9.86 | -12.89 | -42.32 | -80.79 | -20.54 | -37.25 |
| Profit Margin | -16.84 | -22.29 | -65.88 | -85.00 | -21.52 | -48.81 |
| EBITDA | -3.97 Million | -2.78 Million | -3.76 Million | -3.08 Million | -4.29 Million | -2.87 Million |
| Earnings Before Tax Margin | -15.95 | -14.53 | -45.46 | -87.33 | -22.21 | -37.25 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 180.88 Thousand | 606.98 Thousand | 308.87 Thousand | 298.07 Thousand | 315.78 Thousand | 117.82 Thousand |
| Cost of Revenue | 88.3 Thousand | 906.99 Thousand | 541.04 Thousand | 368.6 Thousand | 629.93 Thousand | 323.57 Thousand |
| Gross Profit | 92.57 Thousand | -300 Thousand | -232.17 Thousand | -70.53 Thousand | -314.15 Thousand | -205.74 Thousand |
| Operating Expenses | 3.25 Million | 6.37 Million | 3.21 Million | 3.15 Million | 4.27 Million | 2.32 Million |
| Selling, General and Administrative Expenses | 2.53 Million | - | 2.15 Million | 2.1 Million | - | 1.56 Million |
| Research and Development Expenses | 885.27 Thousand | - | 1.06 Million | 1.05 Million | - | 763.7 Thousand |
| Other Expenses | -172.72 Thousand | - | - | - | - | - |
| Cost and Expenses | 3.33 Million | 7.28 Million | 3.76 Million | 3.52 Million | 4.9 Million | 2.65 Million |
| Operating Income | -3.15 Million | -6.67 Million | -3.45 Million | -3.22 Million | -4.58 Million | -2.53 Million |
| Interest Expense | 57.89 Thousand | 89.63 Thousand | 132.12 Thousand | 5078.80 | 2.5 Million | 384.66 Thousand |
| Income Tax Expense | 5.00 | 3.00 | 2.00 | 4.00 | 5.00 | 4.00 |
| Earnings before Tax | -3.21 Million | -6.78 Million | -3.54 Million | -3.23 Million | -7.04 Million | -2.57 Million |
| Net Income | -3.21 Million | -6.78 Million | -3.54 Million | -3.23 Million | -7.04 Million | -2.57 Million |
| Earnings Per Share Basic | -0.01 | - | -0.01 | -0.01 | - | -0.01 |
| Earnings Per Share Diluted | -0.01 | - | -0.01 | -0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 363.11 Million | 266.25 Million | 286.1 Million | 248.04 Million | 218.86 Million | 248.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 363.09 Million | 266.25 Million | 286.1 Million | 248.04 Million | 218.86 Million | 248.04 Million |
| Gross Margin | 0.51 | -0.49 | -0.75 | -0.24 | -0.99 | -1.75 |
| EBIT Margin | -17.40 | - | -10.02 | -9.80 | - | -19.00 |
| Profit Margin | -17.76 | -11.18 | -11.48 | -10.87 | -22.29 | -21.85 |
| EBITDA | -3.14 Million | - | -3.09 Million | -2.91 Million | - | -2.23 Million |
| Earnings Before Tax Margin | -17.46 | -11.00 | -11.17 | -10.83 | -14.53 | -21.50 |
IS3
ROST
300135
300399
002653
HIQ